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Background: The aim of this work was to examine the risk of lymphohaematopoietic (LH) cancer according to benzene exposure
among offshore workers.
Methods: Cancer registry data were used to identify 112 cancer cases diagnosed during 1999–2011 in a cohort of 24 917
Norwegian men reporting offshore work between 1965 and 1999. Analyses were conducted according to a stratified case–cohort
design with a reference subcohort of 1661 workers. Cox regression was used to estimate hazard ratios with 95% confidence
intervals, adjusted for other benzene exposure and smoking.
Results: Most workers were exposed to benzene for o15 years. The upper range values of average intensity and cumulative
exposure were estimated to 0.040 p.p.m. and 0.948 p.p.m.-years, respectively. Risks were consistently elevated among exposed
workers for all LH cancers combined and for most subgroups, although case numbers were small and yielded imprecise risk
estimates. There was evidence of dose-related risk patterns according to cumulative exposure for acute myeloid leukaemia (AML),
multiple myeloma (MM) (P trends 0.052 and 0.024, respectively), and suggestively so for chronic lymphocytic leukaemia (CLL)
according to average intensity (P trend 0.094).
Conclusions: Our results support an association between cumulative and intensity metrics of low-level benzene exposure and risk
for AML, MM, and suggestively for CLL.
Offshore production of crude oil and natural gas has been carried out
in the North Sea from movable or stationary installations since the
late 1960s. As opposed to the ‘downstream’ petroleum industry, which
refers to refinement and distribution of petroleum products, the
offshore industry is an ‘upstream’ activity and refers to exploration,
drilling, and extraction of oil and gas from underwater reservoirs.
Aromatic hydrocarbons such as benzene, toluene, ethyl-
benzene, and xylene (collectively labelled: BTEX) are natural
components of the petroleum stream and exposure to these
agents in the offshore work environment may occur during
production control and maintenance of the process systems that
separate crude oil, natural gas, condensate, and water (Bråtveit
et al, 2007; Steinsvåg et al, 2007). The International Agency for
Research on Cancer (IARC) has classified benzene as carcino-
genic to humans, giving rise to acute myeloid leukaemia (AML),
and possibly increasing the risk of acute lymphoblastic
leukaemia (ALL), chronic lymphocytic leukaemia (CLL), multiple
myeloma (MM), and non-Hodgkin lymphoma (NHL). Other
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BTEX-hydrocarbons are listed as possible carcinogens or
considered as not classifiable (IARC, 2014).
In 1998, the Cancer Registry of Norway established a cohort of
workers employed offshore between 1965 and 1999 to examine
associations between cancer and potential hazards in the working
environment, whereof benzene’s relation to lymphohaematopoietic
(LH) cancer was of particular interest (Stenehjem et al, 2014). Less
than 400 personal measurements of benzene during 12-h offshore
shifts, all sampled after 1994, existed to assist exposure assessment
for work before 1999, and 95% of them showed concentrations
o0.16 parts per million (p.p.m.), which complies well with the
occupational exposure limit for benzene of 0.6 p.p.m. (Steinsvåg
et al, 2007). Because of the paucity of measurement data, experts
on industrial hygiene developed semi-quantitative exposure
estimates based on information on duration and frequency of job
tasks that involved benzene exposure (Bråtveit et al, 2011, 2012).
Benzene exposure in everyday life has been considered less
important (Duarte-Davidson et al, 2001; IARC, 2012) but may
have a role when effects from low occupational exposures are
addressed.
Historically, NHL has been defined as all lymphomas except
ALL, CLL, MM, and Hodgkins lymphoma (HL). However, the
most recent WHO classification of haematopoietic and lymphoid
tissues considers ALL, CLL, and MM of B-cell lineage to be major
subtypes of B-cell NHL (B-NHL) together with diffuse large B-cell
lymphoma (DLBCL) and follicular lymphoma (FL) (Swerdlow
et al, 2008). Early studies that examined NHL as one entity
(Schnatter et al, 1996; Hayes et al, 1997; Nilsson et al, 1998; Collins
et al, 2003), as well as more recent studies where NHL was
examined by subtypes (Wang et al, 2009; Cocco et al, 2010), have
reported inconsistent findings of benzene-related risks.
For subgroups of myeloid neoplasms, such as AML, chronic
myeloid leukaemia (CML), and myelodysplastic syndrome (MDS),
several studies have provided evidence for benzene-related risks in
both downstream and upstream segments of the petroleum
industry (Rushton, 1993; Schnatter et al, 1996, 2012; Ja¨rvholm
et al, 1997; Rushton and Romaniuk, 1997; Nilsson et al, 1998;
Lewis et al, 2003; Glass et al, 2003, 2014; Sorahan et al, 2005;
Kirkeleit et al, 2008; Rushton et al, 2014), but few studies have
examined such a link for lymphoid neoplasms, among upstream
petroleum workers (Gun et al, 2004, 2006; Kirkeleit et al, 2008),
and only one study used quantitative estimates of benzene
exposure (Glass et al, 2003). Some reports have suggested that
benzene may be leukaemogenic and haematotoxic at low
concentrations (o10 p.p.m. and o0.2 p.p.m., respectively)
(Glass et al, 2003; Hayes et al, 1997; Lan et al, 2004, 2006;
Schnatter et al, 2012; Talbott et al, 2011; Vlaanderen et al, 2010).
Although the link with LH cancers has been studied thoroughly in
recent years, there is limited evidence to decide which character-
istics of benzene exposure are the most relevant for identification
and assessment of LH cancer risk: for example, cumulative
exposure, exposure duration, intensity, or peak exposures
(Collins et al, 2003).
The aim of the present study was to examine risk of LH cancers
in a cohort of 24 917 male offshore workers exposed to low average
concentrations of benzene.
MATERIALS AND METHODS
Study population and study design. No complete and reliable
employment registers of Norwegian offshore workers was available
in the 1990s, and in 1998, the Cancer Registry of Norway therefore
established a cohort by conducting a survey among active and
former offshore workers. Postal questionnaires were distributed to
a roster of 57 328 men and women compiled from personnel lists
of onshore and offshore workers from oil companies, member lists
from labour unions, and lists of participants at offshore safety
courses. Data on work history and lifestyle factors were included in
the questionnaires (appendices) for prospective analysis of cancer
and cause-specific mortality. A total of 27 987 individuals
confirmed having worked offshore on the Norwegian continental
shelf for at least 20 days between 1965 and 1999 (inclusion
criterion), and in a recent study, the survey response rate was
estimated to be 69% among true offshore workers verified by
comparison with the Norwegian State Register of Employers and
Employees (Stenehjem et al, 2014).
For workers with more than two offshore employments, and for
onshore employments, information had to be extracted manually
from the questionnaires. For economic reasons, data extraction was
performed on a random subsample of the cohort only, as well as
for all LH cancers, according to a stratified case–cohort design
(Borgan et al, 2000). We chose to stratify on birth cohorts with the
aim of having a minimum of five controls per cancer case in each
birth cohort. Within each stratum, the subcohort is a representa-
tive sample of the full cohort. This approach is a type of
case–control design that allows fitting prospective models such as
Cox-regression models to the data. A key advantage of the design is
that the controls (sampled non-cases) may be used for different
types of cancer cases, as they are not matched to specific cases.
Female offshore workers were not considered for the present
study due to a low number of subjects (n¼ 2572), and because
most women were employed as administrative and catering
personnel assumed to have low exposure to benzene. A total of
498 subjects were excluded from the full cohort owing to
irregularities in the reporting (Figure 1), and the remaining
24 917 male offshore workers were eligible for sampling of the
subcohort. We drew at random 1675 workers, stratified on 5-year
birth cohorts and frequency matched to the birth year distribution
of all potentially occupational cancers observed through 2009
(n¼ 556). For the present study, 112 LH cancers were identified in
the full cohort.
Based on work histories, the offshore workers were grouped into
four main platform activities (production, drilling, maintenance,
and catering) and 29 job categories. A total of 913 employments
among 615 workers (42 cases and 573 subcohort non-cases) were
grouped according to main activity only (no specific job category
available). Missing start dates for 289 employments among 157
workers (16 cases and 141 subcohort non-cases) were assigned the
average start date within each corresponding birth cohort stratum
(1918–1940, 1941–1949, or 1950–1978) and job category. Missing
stop dates for 328 employments among 196 workers (18 cases and
178 subcohort non-cases) were assigned the average stop date
within each corresponding stratum of start date (1965–1979, 1980–
1989, or 1990–1999) and job category. A total of 457 workers (33
cases and 424 subcohort non-cases) were still employed offshore
when the survey was conducted in 1998, and their jobs were
considered terminated by 31 December 1998.
Participation in the survey was voluntary and based on
informed consent. Necessary legal and ethical approvals were
obtained from the Norwegian Data Inspectorate, the Regional
Committee for Medical Research Ethics, and the Norwegian
Directorate of Health.
Identification of cancer cases. The full cohort (n¼ 24 917) was
linked to the national database of incident cancer diagnoses at the
Cancer Registry of Norway and to the Norwegian National
Population Register for data on vital status, year of death, and year
of emigration, if relevant. Cases were required to be the first LH
cancer diagnosed in each individual between 30 June 1999 and 31
December 2011. The observed 112 LH cancer cases are displayed
by subtype and International Classification of Diseases Tenth
revision (ICD-10) code in Table 1. Reporting of incident cancers to
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the Cancer Registry is compulsory in Norway, and data from a
number of sources ensure a high degree of completeness (Larsen
et al, 2009). Information on cancer localisation was based on a
modified version of the ICD-7 and ICD-10, all converted into ICD-
10 codes. LH cancer subtypes were classified according to the most
recent WHO classification of haematopoietic and lymphoid tissues
(Swerdlow et al, 2008) by using histology codes from the ICD-
Oncology (ICD-O) second revision for the time period 1999–2001
and from the third revision of ICD-O for the time period 2002–
2011. In the analyses, we gradually split the case group into finer
subgroups of LH cancers, in order to display the value of detailed
diagnostic data. CLL was combined with one case of small
lymphocytic lymphoma (SLL) in the main analysis, denoted as
‘CLL’ only. In a supplemental analysis, 11 B-cell CLL cases were
analysed together with 1 CLL case of unknown lineage and 2 cases
of hairy cell leukaemia and without the 1 SLL case according to the
Kiel classification system for non-solid tumors, which were used
with local extensions by the Cancer Registry before 2002 (Larsen
et al, 2009).
Exposure levels. In 2007, Steinsvåg et al (2005, 2007, 2008)
published an expert-developed job time–exposure matrix (JEM) for
selected carcinogens in the Norwegian offshore industry during
1970–2005, specially prepared for the present cohort. In 2011, the
expert group refined the benzene estimates by using more
monitoring data and information on job-specific determinants of
benzene exposure (Bråtveit et al, 2011, 2012). In brief, semi-
quantitative exposure estimates were derived according to a four-
step procedure based on the principles described by Hopf et al,
2010: step 1, identifying relevant tasks associated with benzene
exposure. Tasks were selected based on results from pooled
benzene exposure measurements, most of which were conducted
after year 2000; step 2, for each task, 10 determinants of benzene
exposure (related to exposure source, transmission path, and
individual factors) were scored 0, 1, or 2. Each task was assigned
the mean score of the 10 determinants as the average intensity; step 3,
estimating frequency and duration of the tasks. Task frequency was
assessed as times per work week (t/w) scored 0¼ 0 t/w, 0.5¼
40–1 t/w, 1¼41–7 t/w, and 2¼47 t/w. Task duration was
scored 1¼o15min., 2¼ 15–60min., 3¼460min. An exposure
burden score for each task was created by multiplying scores from
intensity, duration, and frequency. Estimates of exposure burden
scores for each job category were derived by summing the exposure
burden scores for each task divided by nine (the total number of
benzene-related tasks); step 4, the job-specific exposure burden
scores (hereafter JEM-score) had an observed range of 0–2.4. Job
categories were categorised into four groups based on the JEM-
score (group I: 0, group II: 40–p0.5, group III: o0.5–p1.0,
group IV: 41.0). In addition, scores were developed to reflect the
frequency of exceeding the short-term exposure limit (STEL-
score). The Norwegian STEL is 3 p.p.m. measured over a 15-min
sampling period (NLIA, 2011). STEL-scores for each job category
were calculated by assessing whether the STEL was exceeded
‘often’¼ 2, ‘sometimes’¼ 1, or ‘never’¼ 0, when performing the
respective tasks. Then, this number (0, 1 or 2) for each task was
multiplied with the same frequency-score used for the JEM-score
on how often this task was performed (0, 0.5, 1, and 2). Finally,
each task’s product (exceedings times frequency) was summed for
the tasks relevant for each job category, creating a STEL-score (i.e.,
related to benzene exposures 43 p.p.m.). The STEL-score had a
range of 0–9.0, and job categories were categorised into four groups
based on this score (group I: 0, group II: 40–p2.0, group
III: o2.0–p5.0, group IV: 45.0). The benzene JEM and
STEL-matrices are available at http://www.uib.no/filearchive/
supplementary-information-to-the-jem-.pdf (Bråtveit et al, 2011,
2012). JEM and STEL-scores were assessed for 29 job categories for
four 10-year time periods (1970–79, 1980–89, 1990–99, 2000–09).
Offshore cohort
Members of full cohort
(n =27 987)
Offshore cohort
Offshore cohort
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Exclusion of LH cases
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Figure 1. Overview of study design and exclusions.
Table 1. Numbers of lymphohaematopoietic cancer cases by
subtype and code from the International Classification of
Diseases (Tenth revision) among 24917 male Norwegian
offshore oil industry workers followed during 1999–2011
Type of cancer ICD-10 code
No. of
cases
Lymphohaematopoietic (LH) C81–C92, D45–7 112
Lymphoida C81–C91 91
Hodgkin lymphoma (HL)a C81 6
Non-Hodgkin lymphoma (NHL)a C82–C91 85
B-cell NHL (B-NHL) C83–C91 81
Diffuse large B-cell lymphoma (DLBCL) C83.3 22
Follicular lymphoma (FL) C82.0–1, C82.9 15
Mantle cell lymphoma (MCL) C83.1 7
Multiple myeloma (MM) C90.0 17
Chronic lymphocytic leukaemia (CLL) C91.1, C83.0 12
Other B-NHL subtypesa C84–C91 8
T-cell NHL (T-NHL)a C91.6, C84.4 2
NHL of unknown lineagea C85.9, C91.9 2
Myeloid C92, D45–7 21
Acute myeloid leukaemia (AML) C92.0 10
Chronic myeloid leukaemia (CML)a C92.1 3
Myelodysplastic syndrome (MDS)a D46 4
Other myeloid diseasesa D45, D47.3 4
aNot analysed separately.
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Work histories from 1965 to 1969 were assigned scores from the
period 1970 to 1979. Employments described according to main
platform activity only were assigned the average JEM and
STEL-scores of the job categories within the relevant main
platform activity.
In order to facilitate comparison with other studies, the JEM-
scores were translated into corresponding p.p.m. values estimated
on the basis of all available personal benzene measurements on
Norwegian installations from 1994 to 2003. The average level of
0.036 p.p.m. from the 204 samples for process technicians
(Steinsvåg et al, 2007) was judged to correspond to their assigned
JEM-score of 2.1 for the time period 1990–99, giving a ratio
of 0.0171 (0.036/2.1). By multiplying this ratio with average
JEM-scores from 0.05 to 2.35, we estimated a proportional
corresponding range of average p.p.m.-values from 0.0009 to
0.040. In order to show the distribution of individual average
exposure intensities and the corresponding durations of exposure
for all exposed workers, we plotted these values in Figure 2, also
showing the tertiles according to cumulative exposure. The y axes
shows the JEM intensity values (left side) and the translated p.p.m.
values (right side).
Data analysis. Five exposure metrics were derived to reflect
different characteristics of benzene exposure: (1) cumulative
exposure was derived by multiplying the JEM-score and duration
(years) for each employment period, summarising these products
for each individual from the start of employment until 31
December 1998 (range: 0–55.3 JEM-score-years, 0–0.948 p.p.m.-
years); (2) cumulative peak exposure was derived following the
same procedure as cumulative exposure, except using the STEL-
score (range: 0–208.3 STEL-score-years); (3) exposure duration
(range: 0–33.5 years); (4) average exposure intensity (cumulative
exposure divided by exposure duration; range: 0–2.35 JEM-score,
0–0.040 p.p.m.); and (5) an average frequency score of peak
exposures (cumulative peak exposure divided by exposure dura-
tion; range: 0–157 STEL-score). Cut-points for exposure duration
were chosen as ‘40–5.49 years’, ‘5.5–12.9 years’, and ‘13–33.5
years’ to achieve almost equally sized groups among the exposed
workers. Exposure strata for the benzene metrics 1, 2, 4, and 5
above were defined according to tertiles among exposed workers
(labelled T1, T2, T3, the latter representing the highest exposed).
Based on the full case–cohort set (112 cases and 1661 non-cases),
tertiles were labelled with the estimated range of p.p.m.-values
within each tertile for cumulative exposure (metric 1): ‘T1
(o0.001–0.037 p.p.m.-years)’, ‘T2 (40.037–0.123 p.p.m.-years)’,
‘T3 (0.124–0.948 p.p.m.-years)’, and for average exposure intensity
(metric 4): ‘T1 (o0.001–0.007 p.p.m)’, ‘T2 (40.007–0.013 p.p.m)’,
and ‘T3 (40.013–0.040 p.p.m)’. For all analyses, unexposed
workers were used as reference (benzene exposure or
duration¼ 0). ‘Ever’ and ‘never’ (reference) exposed to benzene
were defined as exposure duration 40 years and ¼ 0 years,
respectively, and the corresponding risks were analysed by period
of first employment (1965–1979 and 1980–1998).
Cox regression, adapted to a stratified case–cohort design
(Borgan et al, 2000), was used to estimate hazard ratios (HRs) of
cancer and corresponding 95% confidence intervals (CIs)
associated with the benzene metrics. Cases were assigned a
weight of 1 and subcohort non-cases were given weights
according to the inverse sampling fraction from their corre-
sponding 5-year birth cohort stratum. Robust variances were used
to compute s.es. of the HRs. Age was used as timescale with entry
at age by start of follow-up. Subjects were censored at the date of
cancer diagnosis, date of emigration, date of death, or end of
study, whichever came first. A total of 14 cases were identified as
members of the randomly drawn subcohort and were analysed as
cases only (weight¼ 1) (Borgan et al, 2000). Thus a sample of 112
LH cases and 1661 subcohort non-cases was used in the analyses
(Figure 1).
The robustness of the results was examined by conducting two
sensitivity analyses. First, we analysed the data after excluding
workers who were categorised according to main platform
activity only and excluding workers with replaced start or stop
dates (56 cases and 713 non-cases). Second, we conducted
an analysis where the 457 workers still employed in 1998
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Figure 2. Average benzene exposure intensity (scores derived from an expert-based job–exposure matrix (JEM) on the left y axis and estimated
corresponding p.p.m. values on the right y axis) against duration of exposure among exposed cases and subcohort members in a cohort of
offshore oil industry workers. Workers were divided into tertiles according to cumulative exposure (intensity times duration).
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were assumed to be exposed at the same intensity level until
censoring or end of observation time (methodological details in
Supplementary Material).
In all analyses, HRs were adjusted for potential confounding
effects from age (as the time scale), benzene exposure from other
work (yes, no), and ever being a daily smoker (yes, no, unknown).
Assessment of ‘benzene exposure from other work’ was based on
self-reported job titles and industry sector (question 35 in
questionnaire, appendices). Workers reporting job titles that
included one or more of the keywords: ‘tank’, ‘mechanic’, ‘lab’,
‘painter’, ‘machinist’, ‘refinery’, and ‘chemi’ were assumed to be
exposed to benzene. Similarly, benzene exposure was assumed to
have taken place for workers reporting experience from the
following industry sectors: ‘shipping (bridge, deck, machinist)’,
‘chemical industry’, ‘painting and surface treatment’, ‘farming and
forestry’, and ‘other industry’. Tests for linear trend across
categories were performed by using the median within each
exposure category as a quantitative score. The proportional hazards
assumption was evaluated by Schoenfeld residuals. Tests for
significance were two-sided, and P-values of r0.05 were
considered to represent statistical significance. Data analyses
were performed using Stata version 13.1 (StataCorp, College
Station, TX, USA).
RESULTS
The distribution of exposed workers according to average exposure
intensity and exposure duration is displayed in Figure 2. Most
workers were exposed to benzene for o15 years, and the median
and interquartile range of estimated average intensity, for a 12-h
work shift, were 0.008 p.p.m. and 0.006–0.014 p.p.m., respectively.
Estimated cumulative exposure values varied fromo0.001 to 0.948
p.p.m.-years.
Background characteristics of the case group and non-case
subcohort are shown in Table 2. The distributions of first year of
employment offshore, benzene exposure from other work, and
history of ever being a daily smoker were fairly similar between
cases and non-cases.
Table 3 shows the risk estimates (HRs) for LH cancers according
to ever exposure to benzene. Risk estimates were consistently
elevated among the exposed workers for most LH cancer groups,
except for DLBCL, but none were statistically significant. Risks
among those with first employment offshore before 1980 were
generally higher compared with those with later employment start,
although the number of cases was low and the risk estimates
correspondingly unstable.
Tables 4 and 5 show the effects of different benzene exposure
metrics (cumulative, cumulative peak, duration, average intensity,
and average peak) for all LH cancers combined, for all myeloid
cancers combined, and for AML (Table 4), and for B-NHL and its
major subtypes, including DLBCL, FL, CLL, and MM (Table 5).
For cumulative exposure, risk estimates were elevated for most
cancer outcomes. For all myeloid cancers combined, for AML, and
for MM, risk estimates in the third tertile of exposure was
substantially higher than those in the first and second tertiles.
A statistically significant test for trend was observed for MM
(P trend 0.024), and one of borderline statistical significance for
AML (P trend 0.052).
The risk estimates according to cumulative peak exposure
followed a similar pattern as cumulative exposure, although there
were suggestions of a weaker response. The risk of AML increased
with increasing cumulative peak exposure, but the trend test was
not statistically significant (P trend 0.166).
For most outcomes, exposure duration showed a less convincing
dose–response pattern.
For both average intensity and average peak, risk estimates
were somewhat fluctuating across tertiles of exposure and few
clear patterns were observed. However, the risk of AML increased
with increasing average intensity (P trend 0.092) and STEL
exceedings (P trend 0.056). A similar pattern was found
for MM, where the risk increased with increasing average peak
(P trend 0.130).
For all exposure metrics, the risk of CLL was consistently
elevated among exposed workers, although risk estimates rarely
reached statistical significance. In an additional analysis, CLL was
analysed with other cancers according to the Kiel classification
(Supplementary Table S1, Supplementary Material), and the results
were similar to the main analyses. A dose-related pattern was
suggested for average intensity in both the main and the
supplementary analysis of CLL with P trends of 0.094 and 0.067,
respectively.
No association was found for DLBCL in any of the benzene
exposure metrics.
The analyses shown in Tables 3 and 4 for all LH cancers
combined were repeated with a case–cohort set restricted to
subjects with reported job category and without missing start and
stop dates. The results were largely similar to those presented in
Tables 2–4 (Supplementary Tables S2–S4, Supplementary
Material). The analyses for all LH cancers combined in Table 4
were also repeated where the 457 workers still employed in 1998
were assumed to be exposed until censoring. The results were quite
similar to those presented in Table 4 (Supplementary Table S5,
Supplementary Material).
Table 2. Demographic data, smoking habits, and work-
related data of male lymphohaematopoietc cancer cases
and a subcohort of non-cases among Norwegian offshore
oil industry workers
Casesa Non-cases
N % N %
Total 112 100 1661 100
Year of birth
1915–1919 0 0.0 3 0.2
1920–1924 0 0.0 31 1.9
1925–1929 5 4.4 141 8.4
1930–1934 10 8.9 129 7.8
1935–1939 12 10.7 221 13.3
1940–1944 18 16.1 397 23.9
1945–1949 20 17.9 323 19.5
1950–1954 13 11.6 110 6.6
1955–1959 20 17.9 172 10.3
1960–1964 10 8.9 88 5.3
1965–1969 4 3.6 29 1.8
1970–1974 0 0.0 10 0.6
1975–1979 0 0.0 7 0.4
First employment offshore
1965–1969 4 3.6 48 2.9
1970–1974 12 10.7 187 11.3
1975–1979 43 38.4 621 37.4
1980–1984 22 19.6 348 20.9
1985–1989 22 19.6 284 17.1
1990–1994 5 4.5 115 6.9
1995–1998 4 3.6 58 3.5
Other benzene exposureb
Yes 19 17.0 300 18.1
No 93 83.0 1361 81.9
Ever daily smoker
Yes 80 71.4 1190 71.6
No 24 21.5 349 21.0
Unknown 8 7.1 122 7.4
aAll lymphohaematopoietc cancer cases.
bBenzene exposure from other work (before, after, and in-between offshore work).
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Table 4. Hazard ratios with 95% confidence intervals of all lymphohaematopoietic cancers, all myeloid cancers, and AML
according to benzene exposure among 24917 Norwegian male offshore oil industry workers followed during 1999–2011
Lymphohaematopoietic
(n¼112)
Myeloid (n¼21) AML (n¼10)
Exposure
metric
C NC HRa HRb (95% CI) C NC HRa HRb (95% CI) C NC HRa HRb (95% CI)
Cumulative (p.p.m.-years)c
Unexposed 29 547 1.00 1.00 (reference) 6 547 1.00 1.00 (reference) 2 547 1.00 1.00 (reference)
T1 (o0.001–0.037) 31 368 1.44 1.47 (0.87, 2.50) 5 372 1.09 1.12 (0.31, 4.01) 2 372 1.38 1.40 (0.18, 11)
T2 (40.037–0.123) 24 375 1.28 1.29 (0.74, 2.26) 4 372 1.16 1.12 (0.30, 4.23) 1 374 0.85 0.85 (0.08, 9.29)
T3 (0.124–0.948) 28 371 1.55 1.61 (0.94, 2.76) 6 370 1.98 2.24 (0.65, 7.71) 5 368 4.49 4.85 (0.88, 27)
P trendb 0.207 0.188 0.052
Cumulative peak (43 p.p.m.)c
Unexposed 39 682 1.00 1.00 (reference) 6 682 1.00 1.00 (reference) 2 682 1.00 1.00 (reference)
Tertile 1 26 325 1.27 1.30 (0.77, 2.19) 5 327 1.46 1.51 (0.44, 5.18) 2 327 1.84 1.95 (0.27, 14)
Tertile 2 24 327 1.40 1.41 (0.83, 2.40) 6 325 2.47 2.46 (0.75, 8.10) 3 326 3.57 3.52 (0.61, 20)
Tertile 3 23 327 1.33 1.37 (0.80, 2.34) 4 327 1.75 1.97 (0.51, 7.69) 3 326 3.61 3.92 (0.59, 26)
P trendb 0.326 0.330 0.166
Duration (years exposed)
0 29 547 1.00 1.00 (reference) 6 547 1.00 1.00 (reference) 2 547 1.00 1.00 (reference)
40–5.49 31 395 1.35 1.38 (0.81, 2.35) 5 395 1.02 1.07 (0.30, 3.80) 3 395 1.97 2.04 (0.33, 13)
5.5–12.9 27 362 1.53 1.56 (0.91, 2.66) 6 362 1.82 1.80 (0.52, 6.24) 4 362 3.33 3.39 (0.67, 17)
13–33.5 25 357 1.42 1.44 (0.83, 2.52) 4 357 1.41 1.47 (0.37, 5.88) 1 357 0.96 0.97 (0.08, 11)
P trendb 0.292 0.508 0.880
Average intensity (p.p.m.)c
Unexposed 29 547 1.00 1.00 (reference) 6 547 1.00 1.00 (reference) 2 547 1.00 1.00 (reference)
T1 (o0.001–0.007) 30 369 1.47 1.47 (0.87, 2.50) 2 375 0.50 0.45 (0.09, 2.31) 1 373 0.77 0.76 (0.07, 8.67)
T2 (40.007–0.013) 25 374 1.30 1.32 (0.76, 2.31) 8 368 2.26 2.41 (0.77, 7.53) 3 371 2.46 2.51 (0.41, 15)
T3 (40.013–0.040) 28 371 1.50 1.57 (0.92, 2.66) 5 371 1.42 1.66 (0.48, 5.74) 4 370 3.21 3.47 (0.63, 19)
P trendb 0.168 0.209 0.092
Average peak (43 p.p.m.)c
Unexposed 39 682 1.00 1.00 (reference) 6 682 1.00 1.00 (reference) 2 682 1.00 1.00 (reference)
Tertile 1 27 324 1.48 1.50 (0.90, 2.50) 6 326 2.09 2.09 (0.63, 6.86) 2 327 2.11 2.17 (0.31, 15)
Tertile 2 24 327 1.32 1.33 (0.78, 2.26) 4 327 1.49 1.53 (0.42, 5.58) 2 327 2.16 2.21 (0.30, 16)
Tertile 3 22 328 1.19 1.23 (0.72, 2.10) 5 326 1.91 2.19 (0.65, 7.36) 4 325 4.50 4.87 (0.90, 26)
P trendb 0.478 0.234 0.056
Abbreviations: C¼ cases; CI¼ confidence interval; HR¼ hazard ratio; NC¼ non-cases; T¼ tertile.
aAdjusted for age (as the timescale).
bAdjusted for age (as the timescale); benzene exposure from other work (yes, no); and ever daily smoker (yes, no, unknown).
cCategories were generated according to tertiles among exposed workers. Cut-points for estimated p.p.m. and p.p.m.-years refer to the full case-cohort set (112 C and 1661 NC).
Table 3. Hazard ratios with 95% confidence intervals of lymphohaematopoietic cancers according to benzene exposure and first
employment among 24917 Norwegian male offshore oil industry workers followed during 1999–2011
Benzene exposure Benzene exposure by first employment offshore
Ever vs nevera o1980 ever vs nevera X1980 ever vs nevera
Type of cancer C HRb HRc (95% CI) C HRb HRc (95% CI) C HRb HRc (95% CI)
Lymphohaematopoietic 83 1.42 1.45 (0.94, 2.24) 46 1.51 1.58 (0.84, 2.97) 37 1.28 1.24 (0.69, 2.25)
B-NHL 61 1.48 1.49 (0.90, 2.48) 35 1.49 1.56 (0.77, 3.16) 26 1.38 1.30 (0.63, 2.69)
DLBCL 15 1.02 0.94 (0.39, 2.28) 9 1.32 1.27 (0.35, 4.62) 6 0.76 0.58 (0.19, 1.83)
FL 11 1.40 1.24 (0.40, 3.85) 3 1.29 1.56 (0.13, 18) 8 1.44 1.21 (0.33, 4.50)
MCL 6 2.87 3.64 (0.43, 31) 4 1.72 1.99 (0.20, 20) 2 NA
CLL 11 5.21 5.40 (0.70, 41) 8 3.41 3.40 (0.43, 27) 3 NA
MM 13 1.60 1.64 (0.55, 4.89) 9 3.77 4.02 (0.58, 28) 4 0.74 0.70 (0.17, 2.85)
Myeloid 15 1.35 1.39 (0.51, 3.82) 7 1.59 1.79 (0.32, 10) 8 1.20 1.20 (0.35, 4.14)
AML 8 2.13 2.18 (0.47, 10) 5 NA 3 0.87 0.86 (0.15, 4.82)
Abbreviations: AML¼ acute myeloid leukaemia; C¼ cases among ever exposed; CI¼ confidence interval; CLL¼ chronic lymphocytic leukaemia; DLBCL¼diffuse large B-cell lymphoma;
FL¼ follicular lymphoma; HR¼ hazard ratio; MCL¼mantle cell lymphoma; MM¼multiple myeloma; NA¼ not applicable (no cases among never exposed); NHL¼ non-Hodgkin lymphoma.
aReference category.
bAdjusted for age (as the timescale).
cAdjusted for age (as the timescale); benzene exposure from other work (yes, no); and ever daily smoker (yes, no, unknown).
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DISCUSSION
This study was designed to examine risk of LH cancers according
to different metrics of benzene exposure in a cohort of male
Norwegian offshore workers with their first offshore employment
between 1965 and 1999. Our primary expectations were to identify
elevated risks of the specific diseases listed by IARC as known or
suspected to be caused by benzene exposure: AML, ALL, CLL, and
MM (IARC, 2012). Although the exposure levels were low (o0.040
avg. p.p.m. and o1 p.p.m.-yrs.), the overall picture was one of an
increased risk of LH cancer among the exposed, who constituted
two-thirds of the cohort. There were evidence of dose-related
patterns for cumulative exposure, exposure intensity, and peak
exposures for AML, for MM, and suggestively for CLL.
Our findings are generally in line with other studies conducted
in petroleum workers or other benzene-exposed workers. Kirkeleit
et al (2008) reported a three-fold increased risk of AML in
Norwegian upstream operators employed before 1985 compared
with an economically active and geographically matched reference
group. An Australian study reported a seven-fold increased risk of
acute non-lymphocytic leukaemia among petroleum workers
exposed to 48 p.p.m.-years (Glass et al, 2003). Further, a study
in UK petroleum marketing and distribution workers reported
increased risks of AML or monocytic leukaemia in relation to
cumulative, duration, and intensity metrics of benzene (Rushton
and Romaniuk, 1997). A Canadian study did not report any
association between risk of leukaemia (all subtypes combined) and
cumulative benzene exposure (Schnatter et al, 1996), but the
chosen reference category included 10 out of the 14 cases with
exposure up to 0.45 p.p.m-years, which may have hampered the
identification of risks at any level. A recent pooled analysis of the
Canadian, the Australian, and the UK data, comprising a total of
60 AML cases, showed an elevated risks of AML according to
cumulative, intensity, duration, and peak metrics of benzene
exposure (Schnatter et al, 2012; Rushton et al, 2014), although
there was little evidence of a dose-related pattern. In contrast to the
pooled analysis, and in line with our results, a study of leukaemia
risk in relation to gasoline spill in Pennsylvania, USA suggested a
dose–response relationship between atmospheric benzene levels
o1 p.p.m. and AML (Talbott et al, 2011). Moreover, recent studies
have detected genotoxic effects and altered gene expression linked
to leukaemia among workers exposed to low levels of benzene (i.e.,
o1 p.p.m.), which supports a biological plausability for a dose–
response relation between average benzene levels o1 p.p.m and
AML risk (Angelini et al, 2011; McHale et al, 2011; Li et al, 2014).
The elevated risks observed for CLL in our study are consistent
with the findings in the Australian and UK studies (Rushton and
Romaniuk, 1997; Glass et al, 2003). A recent review and meta-
analysis addressed the association between lymphoma subtypes
and benzene exposure by stratifying occupational studies according
to three quality dimensions: classification of lymphomas, known to
be better after 1970; quality of exposure assessment; and strength
of the association between AML risk and benzene exposure
(Vlaanderen et al, 2011). The latter criterion served as a quality
measure for the exposure estimates, and a similar evaluation would
add support to the present study. The meta-analysis provided
evidence that CLL is associated with occupational benzene
exposure, in line with our results. Another large case–control
study also suggested a link between benzene exposure and CLL
(Cocco et al, 2010).
Our data suggested increased risks of MM for all exposure
metrics, with a statistically significant trend test for cumulative
exposure. These results accord with those published by Kirkeleit
et al (2008) of increased risk of MM in upstream operators
employed offshore before 1985 and with similar findings in
two meta-analyses (Infante, 2006; Vlaanderen et al, 2011).
The Australian study, however, reported no association between
benzene exposure and risk of MM, although a weakness was that
MM was combined with NHL (Glass et al, 2003).
In their most recent evaluation of benzene as a carcinogen, the
IARC pointed out that NHL is a heterogeneous group of
histological subtypes and that few cohort studies have reported
benzene-related risks of NHL by histological subtype according to
the present day understanding (IARC, 2012). When we examined
B-NHL as one entity, cumulative exposure and exposure duration
suggested dose-related patterns. Even the lack of an association
between exposure metrics for benzene and DLBCL and the
opposite for CLL correspond with the findings of Cocco et al
(2010), while another study suggested a closer relationship between
benzene and DLBCL compared with CLL (Wang et al, 2009).
Interestingly, the observed risk patterns for MM and CLL
correspond to the finding of benzene toxicity to B-cells in the bone
marrow at occupational benzene exposure o0.2 p.p.m. (Lan et al,
2004, 2006). Also, immunosuppression of T-cells mediated by
benzene reduces the immunosurveillance and thus the ability to
prevent B-cell neoplasia (IARC, 2012).
It is an ongoing discussion what metric is most closely
associated with benzene-related risks (Collins et al, 2003). Our
data suggested a stronger link between LH cancer and cumulative,
intensity, and peak metrics, compared with exposure duration. This
may, however, depend on study-specific contrasts within the
exposure metrics. Also, time period of exposure seemed to have a
role on LH cancer risk. The observed elevated risks among those
with first exposure before 1980, compared with those with a later
employment start, are probably explained by reduced exposure
levels as a result of technological improvements during the 1980s
and 1990s (e.g., closing open fluid flow lines, more efficient
ventilation systems, etc.) (Steinsvåg et al, 2006, Stenehjem et al,
2015).
Generally, adjustment for benzene exposure from other work
and from smoking had negligible effects on the HRs, and no
change of direction occurred except for estimates close to the null,
in agreement with a low degree of confounding. Still, our
adjustment was rather crude and residual confounding, of both
directions, cannot be ruled out.
Important strengths of our study were the prospective case–
cohort design, the independent outcome data from a high-quality
national cancer registry, virtually complete linkage based on
unique personal identity numbers, and the access to independent
exposure estimates developed by industrial hygiene experts
specifically for cancer studies in our cohort.
On the other hand, some of the workers reported occupations
from up to three decades before the start of follow-up. The long
time span may introduce recall differences, although self-reported
occupational history has been found to be quite robust (Wa¨rneryd
et al, 1991). Further, we were unable to allow for individual
differences in exposure within each occupational group. Average
exposure intensity of benzene was estimated for typical workers
within the respective job categories in three time periods but did
not allow for variability in exposure across installations and oil
fields. Some degree of exposure misclassification obviously exists in
our data. The potential recall bias in the occupational histories
would possibly be related to age, rather than to disease status.
A bias towards the null therefore seems to be the most likely effect.
We also had no information on work experience and exposures
after 1999 for the study subjects, but the sensitivity analysis
indicated no substantial bias from this shortcoming. Moreover, the
observed risk pattern for AML indicated that the benzene exposure
estimates for the present study were satisfactory, at least on a
relative scale. We therefore consider benzene as a strong candidate
to explain the observed risk pattern, and we find it unlikely that
bias, confounding, or chance should create an overall picture like
the one seen in our study.
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Measurements of benzene exposure had mainly been con-
ducted among process operators after year 2000 (Bråtveit et al,
2011, 2012), and a semi-quantitative expert assessment was
chosen in order to take into account exposure differences on a
work-task level back in time. The average exposure concentration
in p.p.m. for process technicians was estimated to correspond to
the process technicians’ semi-quantitative JEM-score for the
period 1990–1999, based on available measurements, knowledge
of the actual conditions, and performed tasks during sampling.
The transformation of JEM-scores to p.p.m. levels carries
uncertainty as no measurement data from before 1990 existed,
neither to indicate job-specific p.p.m. levels nor to describe the
relationship (proportionality) between the semi-quantitative
scores and actual p.p.m. levels.
In conclusion, our analyses indicated that there is an increased risk
of LH cancer among benzene-exposed offshore workers, compared
with unexposed, on the Norwegian continental shelf. The 12-h shift
average intensity levels were estimated to be o0.040 p.p.m., and the
cumulative levels to be o1 p.p.m.-years. There was evidence of a
dose-related risk pattern according to exposure intensity and
cumulative exposure for AML, for MM, and suggestively for CLL.
ACKNOWLEDGEMENTS
We wish to thank our former Head of Department, Aage
Andersen, without whose efforts the establishment of the cohort
and the conduct of the subsequent studies would not have been
possible, Researcher Leif Åge Strand for conducting the offshore
survey, Senior Consultant Tone Eggen for cleaning the work
history data, Data Manager Jan Ivar Martinsen for sampling of the
subcohort and linking cancer and exposure estimates to the cohort,
and MD Svein Hansen for advice on grouping of LH cancer
(Department of Research, Cancer Registry of Norway). We also
thank Industrial Hygienists Jorunn Kirkeleit and Bjørg Eli Hollund
(Department of Occupational Medicine, Haukeland University
Hospital, Norway) and Research Director John Cherrie (Institute
of Occupational Medicine, Edinburgh, UK) for assisting with the
JEM development. This work was funded by the Research Council
of Norway’s PETROMAKS program (grant no. 189612).
CONFLICT OF INTEREST
The authors declare no conflict of interest.
REFERENCES
Angelini S, Kumar R, Bermejo JL, Maffei F, Barbieri A, Graziosi F, Carbone F,
Cantelli-Forti G, Violante FS, Hemminki K, Hrelia P (2011) Exposure
to low environmental levels of benzene: evaluation of micronucleus
frequencies and S-phenylmercapturic acid excretion in relation to
polymorphisms in genes encoding metabolic enzymes. Mut Res
719(1-2): 7–13.
Borgan Ø, Langholz B, Samuelsen SO, Goldstein L, Pogoda J (2000)
Exposure stratified case-cohort designs. Life Data Anal 6(1): 39–58.
Bråtveit M, Kirkeleit J, Hollund BE, Moen BE (2007) Biological monitoring
of benzene exposure for process operators during ordinary activity
in the upstream petroleum industry. Ann occup Hyg 51(5): 487–494.
Bråtveit M, Kirkeleit J, Hollund BE, Vågnes KS, Abrahamsen EH (2011)
Retrospective JEM for benzene in the Norwegian oil and gas industry.
Conference abstractOccup Environ Med 68(Suppl 1): A26.
Bråtveit M, Hollund BE, Kirkeleit J, Abrahamsen EH (2012) Supplementary
information to the Job Exposure Matrix for benzene, asbestos and oil mist/
oil vapour among Norwegian offshore workers. Report. University of
Bergen: Bergen, Norway, Available from: http://www.uib.no/filearchive/
supplementary-information-to-the-jem-.pdf (accessed 20 January 2013).
Cocco P, t’Mannetje A, Fadda D, Melis M, Becker N, de Sanjose´ S, Foretova L,
Mareckova J, Staines A, Kleefeld S, Maynadie´ M, Nieters A, Brennan P,
Boffetta P (2010) Occupational exposure to solvents and risk of lymphoma
subtypes: results from the Epilymph case–control study. Occup Environ
Med 67(5): 341–347.
Collins JJ, Ireland B, Buckley CF, Shepperly D (2003) Lymphohaematopoeitic
cancer mortality among workers with benzene exposure. Occup Environ
Med 60(9): 676–679.
Duarte-Davidson R, Courage C, Rushton L, Levy L (2001) Benzene in the
environment: an assessment of the potential risks to the health of the
population. Occup Environ Med 58(1): 2–13.
Glass DC, Gray CN, Jolley DJ, Gibbons C, Sim MR, Fritschi L, Adams GG,
Bisby JA, Manuell R (2003) Leukemia risk associated with low-level
benzene exposure. Epidemiology 14(5): 569–577.
Glass DC, Schnatter AR, Tang G, Irons RD, Rushton L (2014) Risk of
myeloproliferative disease and chronic myeloid leukaemia following
exposure to low-level benzene in a nested case-control study of petroleum
workers. Occup Environ Med 71(4): 266–274.
Gun RT, Pratt NL, Griffith EC, Adams GG, Bisby JA, Robinson KL (2004)
Update of a prospective study of mortality and cancer incidence in the
Australian petroleum industry. Occup Environ Med 61(2): 150–156.
Gun RT, Pratt N, Ryan P, Roder D (2006) Update of mortality and cancer
incidence in the Australian petroleum industry cohort. Occup Environ
Med 63(7): 476–481.
Hayes RB, Yin S-N, Dosemeci M, Li G-L, Wacholder S, Travis LB, Li CY,
Rothman N, Hoover RN, Linet MS (1997) Benzene and the dose-related
incidence of hematologic neoplasms in China. J Natl Cancer Inst 89(14):
1065–1071.
Hopf NB, Waters MA, Ruder AM, Prince MM (2010) Development of a
retrospective job exposure matrix for PCB-exposed workers in capacitor
manufacturing. J Occup Health 52(4): 199–208.
Infante PF (2006) Benzene exposure and multiple myeloma: a detailed meta-
analysis of benzene and cohort studies. Ann NY Acad Sci 1076: 90–109.
IARC (2012) International Agency for Research on Cancer: monograph on the
evaluation of the carcinogenic risk of chemicals, Vol. 100F. WHO: Lyon,
France.
IARC (2014) International Agency for Research on Cancer: agents classified by
the IARC monographs, Vol. 1–109. IARC monographs on the evaluation of
the carcinogenic risks to humans. IARC: Lyon, France, updated 14 January
2014. Available from: http://monographs.iarc.fr/ENG/Classification/
ClassificationsAlphaOrder.pdf (accessed 1 March 2014).
Ja¨rvholm B, Mellblom B, Norrman R, Nilsson R, Nordlinder R (1997) Cancer
incidence of workers in the Swedish petroleum industry. Occup Environ
Med 54(9): 686–691.
Kirkeleit J, Riise T, Bråtveit M, Moen BE (2008) Increased risk of acute
myelogenous leukemia and multiple myeloma in a historical cohort of
upstream petroleum workers exposed to crude oil. Cancer Causes Control
19(1): 13–23.
Lan Q, Zhang L, Li G, Vermeulen R, Weinberg RS, Dosemeci M, Rappaport SM,
Shen M, Alter BP, Wu Y, Kopp W, Waidyanatha S, Rabkin C, Guo W,
Chanock S, Hayes RB, Linet M, Kim S, Yin S, Rothman N, Smith MT
(2004) Hematotoxicity in workers exposed to low levels of benzene.
Science 306(5702): 1774–1776.
Lan Q, Vermeulen R, Zhang L, Li G, Rosenberg PS, Alter BP, Sehn M,
Rappaport SM, Weinberg RS, Chanock S, Waidyanatha S, Rabkin C,
Hayes RB, Linet M, Kim S, Yin S, Rothman N, Smith MT (2006) Response
to the letter ‘‘benzene exposure and hematotoxicity’’ by Lamm SH and
Gru¨nwald HW. Science 312(5776): 998–999.
Larsen IK, Småstuen M, Johannesen TB, Langmark F, Parkin DM, Bray F,
Møller B (2009) Data quality at the Cancer Registry of Norway: an
overview of comparability, completeness, validity and timeliness.
Eur J Cancer 45(7): 1218–1231.
Lewis RJ, Schnatter AR, Drummond I, Murray N, Thompson FS, Katz AM,
Jorgensen G, Nicolich MJ, Dahlman D, The´riault G (2003) Mortality and
cancer morbidity in a cohort of Canadian petroleum workers. Occup
Environ Med 60(12): 918–928.
Li K, Jing Y, Yang C, Liu S, Zhao Y, He X, Li F, Han J, Li G (2014) Increased
leukemia-associated gene expression in benzene-exposed workers. Sci Rep
4(5369): 1–5.
McHale CM, Zhang L, Lan Q, Vermeulen R, Li G, Hubbard AE, Porter KE,
Thomas R, Portier CJ, Shen M, Rappaport SM, Yin S, Smith MT, Rothman N
(2011) Global gene expression profiling of a population exposed to a range
of benzene levels. Environ Health Perspect 119(5): 628–634.
Benzene and cancer in offshore workers BRITISH JOURNAL OF CANCER
www.bjcancer.com |DOI:10.1038/bjc.2015.108 1611
Nilsson RI, Nordlinder R, Ho¨rte L-G, Ja¨rvholm B (1998) Leukaemia,
lymphoma, and multiple myeloma in seamen on tankers. Occup Environ
Med 55(1): 517–521.
Norwegian Labour Inspection Authorities (NLIA) (2011) Veiledning om
administrative normer for forurensning i arbeidsatmosfære [Guidelines
on occupational exposure limits for polution in the working atmosphere].
Report no. 326 in Norwegian. NLIA: Trondheim, Norway, updated
December 2011. Available from: http://www.arbeidstilsynet.no/binfil/
download2.php?tid=77907 (accessed 27 January 2015).
Rushton L (1993) A 39-year follow-up of the U.K. oil refinery and distribution
center studies: results for kidney cancer and leukaemia. Environ Health
Persp 101(Suppl. 6): 77–84.
Rushton L, Romaniuk H (1997) A case-control study to investigate the risk of
leukaemia associated with exposure to benzene in petroleum marketing
and distribution workers in the United Kingdom. Occup Environ Med
54(3): 152–166.
Rushton L, Schnatter AR, Tang G, Glass DC (2014) Acute myeloid and
chronic lymphoid leukaemias and exposure to low-level benzene among
petroleum workers. Br J Cancer 110(3): 783–787.
Schnatter AR, Armstrong TW, Nicolich MJ, Thompson FL, Katz AM,
Huebner WW, Pearlman ED (1996) Lymphohaematopoietic malignancies
and quantitative estimates of exposure to benzene in Canadian petroleum
distribution workers. Occup Environ Med 53(11): 773–781.
Schnatter AR, Glass DC, Tang G, Irons RD, Rushton L (2012) Myelodysplastic
syndrome and benzene exposure among petroleum workers: an
international pooled analysis. J Natl Cancer Inst 104(22): 1724–1737.
Sorahan T, Kinlen LJ, Doll R (2005) Cancer risk in a historical UK cohort of
benzene exposed workers. Occup Environ Med 62(4): 231–236.
Steinsvåg K, Bråtveit M, Moen BE (2005) Eksponering for kreftfremkallende
faktorer i norsk offshore petroleumsvirksomhet 1970–2005. [Exposure to
carsinogenic agents in the Norwegian offshore petroleum industry
1970–2005]. Report in Norwegian. University of Bergen: Bergen, Norway.
Steinsvåg K, Bråtveit M, Moen BE (2006) Exposure to carcinogens for defined
job categories in Norway’s offshore petroleum industry, 1970 to 2005.
Ann Occup Hyg 50(2): 109–122.
Steinsvåg K, Bråtveit M, Moen BE (2007) Exposure to carcinogens for defined
job categories in Norway’s offshore petroleum industry, 1970 to 2005.
Occup Environ Med 64(4): 250–258.
Steinsvåg K, Bråtveit M, Moen B, Austgulen LV, Hollund BE, Haaland IM,
Naerheim J, Svendsen K, Kromhout H (2008) Expert assessment of
exposure to carcinogens in Norway’s petroleum oil industry. J Expo Sci
Environ Epidemiol 18(2): 175–182.
Stenehjem JS, Kjærheim K, Rabanal KS, Grimsrud TK (2014) Cancer
incidence among 41 000 offshore oil industry workers. Occup Med (Lond)
64(7): 539–545.
Stenehjem JS, Friesen MC, Eggen T, Kjærheim K, Bråtveit M, Grimsrud TK
(2015) Self-reported occupational exposures among 28,000 offshore
oil industry workers employed between 1965 and 1999. J Occup
Environ Hyg; e-pub ahead of print 11 February 2015; doi:10.1080/
15459624.2014.989358.
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J,
Vardiman JW (2008) WHO Classification of Tumours of Haematopoietic
and Lymphoid Tissues. International Agency for Research on Cancer:
Lyon, France.
Talbott EO, Xu X, Youk AO, Rager JR, Malek AM (2011) Risk of leukemia
as a result of community exposure to gasoline vapors: a follow-up study.
Environ Res 111(4): 597–602.
Vlaanderen J, Portengen L, Rothman N, Lan Q, Kromhout H, Vermeulen R
(2010) Flexible meta-regression to assess the shape of the benzene-
leukemia exposure-response curve. Environ Health Persp 118(4): 526–532.
Vlaanderen J, Lan Q, Kromhout H, Rothman N, Vermeulen R (2011)
Occupational benzene exposure and the risk of lymphoma subtypes:
A meta-analysis of cohort studies incorporating three study quality
dimensions. Environ Health Persp 119(2): 159–167.
Wang R, Zhang Y, Lan Q, Holford TR, Leaderer B, Zahm SH, Boyle P,
Dosemeci M, Rothman N, Zhu Y, Qin Q, Zheng T (2009) Occupational
exposure to solvents and risk of non-Hodgkin lymphoma in Conneticut
women. Am J Epidemiol 15(169): 176–185.
Wa¨rneryd B, Thorslund M, Ostlin P (1991) The quality of retrospective
questions about occupational history–a comparison between survey
and census data. Scand J Soc Med 19(1): 7–13.
This work is published under the standard license to publish agree-
ment. After 12 months the work will become freely available and
the license terms will switch to a Creative Commons Attribution-
NonCommercial-Share Alike 4.0 Unported License.
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)
BRITISH JOURNAL OF CANCER Benzene and cancer in offshore workers
1612 www.bjcancer.com |DOI:10.1038/bjc.2015.108
